Undermining Value-Based Purchasing — Lessons from the Pharmaceutical Industry

Although it's not yet clear how health care providers will respond to value-based payment models, an examination of pharmaceutical industry practices can provide insights into problems that may arise — and practices to avoid. In 2015, the U.S. Department of Health and Human Services announced a...

Celý popis

Podrobná bibliografie

Vydáno v:	The New England journal of medicine Ročník 375; číslo 21; s. 2013 - 2015
Hlavní autoři:	Dafny, Leemore S, Ody, Christopher J, Schmitt, Matthew A
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Massachusetts Medical Society 24.11.2016
Témata:	Brand names Consumers Cost Sharing Discount coupons Drug Costs Drug Industry - economics Medicare - economics Pharmaceutical industry Prescription drugs Prescription Fees United States Value-Based Purchasing United States > US Virginia
ISSN:	0028-4793, 1533-4406
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!